Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
80.46
+3.59 (4.67%)
At close: Mar 9, 2026, 4:00 PM EDT
78.86
-1.60 (-1.99%)
After-hours: Mar 9, 2026, 7:06 PM EDT
Bright Minds Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| Market Capitalization | 793 | 429 | 5 | 6 | 20 | 85 | |
| Market Cap Growth | 240.16% | 8742.00% | -18.98% | -70.74% | -75.79% | - | |
| Enterprise Value | 728 | 393 | 0 | 0 | 14 | 67 | |
| Last Close Price | 80.46 | 60.66 | 1.17 | 1.60 | 6.15 | 35.71 | |
| PB Ratio | 12.18 | 7.29 | 1.19 | 1.23 | 2.67 | 5.51 | |
| P/TBV Ratio | 12.18 | 7.29 | 1.19 | 1.23 | 2.67 | 5.52 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.02 | 0.01 | 0.01 | - | |
| Net Debt / Equity Ratio | -1.00 | -1.01 | -1.01 | -1.01 | -1.09 | -1.02 | |
| Quick Ratio | 56.59 | 35.68 | 10.92 | 24.16 | 8.00 | 31.12 | |
| Current Ratio | 57.37 | 36.10 | 11.32 | 24.26 | 8.11 | 31.38 | |
| Return on Equity (ROE) | -26.98% | -27.93% | -46.18% | -86.02% | -99.95% | -85.94% | |
| Return on Assets (ROA) | -15.72% | -18.80% | -25.28% | -47.45% | -57.32% | -51.52% | |
| Return on Capital Employed (ROCE) | -21.00% | -16.60% | -47.10% | -109.10% | -138.80% | -44.40% | |
| Earnings Yield | -1.82% | -2.04% | -42.70% | -90.90% | -53.20% | -8.09% | |
| Buyback Yield / Dilution | -48.78% | -59.58% | -15.87% | -50.58% | -37.64% | -148.42% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.